Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$245M |
| 2 |
KeyCorp
KEY
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$183M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$170M |
| 5 |
Ralph Lauren
RL
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$245M |
| 2 |
US Bancorp
USB
|
+$216M |
| 3 |
Apple
AAPL
|
+$207M |
| 4 |
Visa
V
|
+$188M |
| 5 |
Bank of America
BAC
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 44.36% |
| 2 | Financials | 9.66% |
| 3 | Consumer Discretionary | 8.08% |
| 4 | Energy | 7.72% |
| 5 | Technology | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5801
CALL
Brown & Brown
BRO
$20B
| $39K | ﹤0.01% |
2,400
-2,600
| -52% | -$42.5K |
2013 Q2
1 quarter
|
|
5802
PUT
Daktronics
DAKT
$864M
| $39K | ﹤0.01% |
3,500
-2,100
| -38% | -$23.2K |
2013 Q2
1 quarter
|
|
5803
CALL
Protalix BioTherapeutics
PLX
$218M
| $39K | ﹤0.01% |
860
+370
| +76% | +$19K |
2013 Q2
1 quarter
|
|
|
SIFY
5804
Sify Technologies
SIFY
$964M
| $39K | ﹤0.01% |
+3,603
| New | +$39.8K |
2013 Q3
0 quarters
|
|
5805
PUT
Steris
STE
$20.3B
| $39K | ﹤0.01% |
900
-100
| -10% | -$4.34K |
2013 Q2
1 quarter
|
|
|
VRE
5806
CALL
DELISTED
Veris Residential
VRE
| $39K | ﹤0.01% |
1,800
+200
| +13% | +$4.56K |
2013 Q2
1 quarter
|
|
5807
CALL
Xylem
XYL
$23.8B
| $39K | ﹤0.01% |
1,400
-2,800
| -67% | -$74.6K |
2013 Q2
1 quarter
|
|
|
MNI
5808
CALL
DELISTED
The McClatchy Company Class A Common Stock
MNI
| $39K | ﹤0.01% |
1,300
+400
| +44% | +$11.9K |
2013 Q2
1 quarter
|
|
|
ANW
5809
PUT
DELISTED
Aegean Marine Petroleum Network
ANW
| $39K | ﹤0.01% |
3,300
+600
| +22% | +$5.77K |
2013 Q2
1 quarter
|
|
|
SIRO
5810
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
| $39K | ﹤0.01% |
584
-226,921
| -100% | -$15.3M |
2013 Q2
1 quarter
|
|
|
ROYL
5811
CALL
DELISTED
ROYALE ENERGY INC
ROYL
| $39K | ﹤0.01% |
14,500
-600
| -4% | -$1.66K |
2013 Q2
1 quarter
|
|
|
ASIA
5812
CALL
DELISTED
ASIAINFO-LINKAGE INC COM STK (DE)
ASIA
| $39K | ﹤0.01% |
3,400
-2,000
| -37% | -$23.1K |
2013 Q2
1 quarter
|
|
|
PLCM
5813
PUT
DELISTED
POLYCOM INC
PLCM
| $39K | ﹤0.01% |
3,600
+1,100
| +44% | +$11.5K |
2013 Q2
1 quarter
|
|
5814
CALL
Entravision Communication
EVC
$681M
| $38K | ﹤0.01% |
+6,400
| New | +$37K |
2013 Q3
0 quarters
|
|
|
EXK
5815
CALL
Endeavour Silver
EXK
$2.55B
| $38K | ﹤0.01% |
8,800
-5,100
| -37% | -$21.7K |
2013 Q2
1 quarter
|
|
5816
PUT
National CineMedia
NCMI
$198M
| $38K | ﹤0.01% |
200
+100
| +100% | +$18.2K |
2013 Q2
1 quarter
|
|
|
PBT
5817
PUT
Permian Basin Royalty Trust
PBT
$1.47B
| $38K | ﹤0.01% |
2,700
-11,200
| -81% | -$152K |
2013 Q2
1 quarter
|
|
|
CORV
5818
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $38K | ﹤0.01% |
10,782
+4,918
| +84% | +$11.2K |
2013 Q2
1 quarter
|
|
|
NXTM
5819
CALL
DELISTED
NxStage Medical Inc.
NXTM
| $38K | ﹤0.01% |
2,900
-1,000
| -26% | -$13.1K |
2013 Q2
1 quarter
|
|
|
IDIX
5820
PUT
DELISTED
IDENIX PHARMACEUTICALS INC
IDIX
| $38K | ﹤0.01% |
7,300
+3,300
| +83% | +$14.5K |
2013 Q2
1 quarter
|
|
|
BRD
5821
DELISTED
BRIGUS GOLD CORP COM STK
BRD
| $38K | ﹤0.01% |
+64,154
| New | +$35.4K |
2013 Q3
0 quarters
|
|
|
KNGT
5822
CALL
DELISTED
KNIGHT TRANSPORTATION INC
KNGT
| $38K | ﹤0.01% |
2,300
+800
| +53% | +$13.2K |
2013 Q2
1 quarter
|
|
5823
Barings BDC
BBDC
$904M
| $37K | ﹤0.01% |
1,257
-4,282
| -77% | -$125K |
2013 Q2
1 quarter
|
|
5824
CALL
FerroAtlántica
GSM
$796M
| $37K | ﹤0.01% |
2,400
-7,200
| -75% | -$92K |
2013 Q2
1 quarter
|
|
|
STKL
5825
PUT
DELISTED
SunOpta
STKL
| $37K | ﹤0.01% |
3,800
+1,000
| +36% | +$8.85K |
2013 Q2
1 quarter
|
|
Similar funds
Citadel Advisors's Q3 2013 Portfolio in Review
As of Q3 2013, Citadel Advisors held 7,215 positions worth $65.7B, up 13% from $58.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Citadel Advisors withdrew a net $4.68B in Q3 2013, closing 505 positions and reducing 3,074 holdings. Its most notable exit was NEWS CORPORATION CL-A, an estimated $166M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, up from 41% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in ELAN CORP ADS(RP1 ORD4IRISH PN worth $100M.
- Citadel Advisors's largest Q3 2013 buy was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M.
- Citadel Advisors added most to Philip Morris in Q3 2013, an estimated $245M increase.
- Citadel Advisors's biggest Q3 2013 reduction was Pfizer, cutting an estimated $245M.
- Citadel Advisors fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $166M.
- Citadel Advisors's ten largest holdings make up 12% of its $65.7B portfolio in Q3 2013.
- Citadel Advisors opened 734 new positions and closed 505 in Q3 2013.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $65.7B.
Based on Citadel Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.